The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

GeopoliticsMedium•3 April 2026•

1 min read

Swiss Pharma Industry Warns 100% US Tariffs Threaten Global Supply Chains

Donald Trump speaking in front of U.S. flags at a political event

Key Facts

1Switzerland's pharmaceutical association Interpharma warned that 100% U.S. tariffs on the industry threaten global production and supply chains.

2The association emphasized that these trade measures will ultimately harm patients.

Switzerland's pharmaceutical association, Interpharma, has issued a stark warning regarding the potential impact of proposed 100% U.S. tariffs on the industry. The association stated that such aggressive trade measures would significantly threaten global production and disrupt critical supply chains. Major Swiss exporters, including industry giants Roche and Novartis, face substantial risks as the U.S. remains their largest market. Interpharma emphasized that these tariffs would ultimately lead to increased costs and harm patient health globally. The proposed policies by the Trump administration have sparked widespread concern across the healthcare sector and international trade bodies. Market analysts suggest that these developments could create significant headwinds for pharmaceutical stocks and the Swiss Franc.